Literature DB >> 15125133

The ferguson medial approach for open reduction of developmental dysplasia of the hip. A clinical and radiological review of 49 hips.

N Kiely1, U Younis, J B Day, T M Meadows.   

Abstract

The results of the Ferguson medial approach for open reduction of developmental dysplasia of the hip (DDH) were reviewed for 49 hips with a follow-up of more than 48 months. The mean age at operation was 12.3 months (6 to 23). The mean length of clinical and radiological follow-up was 82 months (48 to 148). Three redislocations occurred. Group I avascular necrosis according to the classification of Kalamchi and MacEwen was seen in four hips, group II in two hips and group III in one hip; 92% of the hips were classified as Severin class I and II. The acetabular index and centre edge (CE) angles were within normal limits at final follow-up, but were still significantly different from the unaffected side. We conclude that the Ferguson procedure is safe and reliable for low dislocations in children aged six to 18 months.

Entities:  

Mesh:

Year:  2004        PMID: 15125133     DOI: 10.1302/0301-620x.86b3.14064

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  16 in total

Review 1.  Is Age or Surgical Approach Associated With Osteonecrosis in Patients With Developmental Dysplasia of the Hip? A Meta-analysis.

Authors:  Eduardo N Novais; Mary K Hill; Patrick M Carry; Patricia C Heyn
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

2.  Developmental Dislocation of the Hip Successfully Treated by Preoperative Traction and Medial Open Reduction: A 22-year Mean Followup.

Authors:  P Farsetti; R Caterini; V Potenza; E Ippolito
Journal:  Clin Orthop Relat Res       Date:  2015-04-01       Impact factor: 4.176

3.  Osteonecrosis and femoro-acetabular impingement: sequelae of developmental dysplasia of the hip.

Authors:  Jason Pui Yin Cheung; Wang Chow; Michael To
Journal:  BMJ Case Rep       Date:  2012-03-20

4.  Ligamentum Teres Transfer During Medial Open Reduction in Patients with Developmental Dysplasia of the Hip.

Authors:  Conner Paez; Raghav Badrinath; Joshua Holt; James D Bomar; Scott J Mubarak; Vidyadhar V Upasani; Dennis R Wenger
Journal:  Iowa Orthop J       Date:  2021

5.  Long-term outcome of Ludloff's medial approach for open reduction of developmental dislocation of the hip in relation to the age at operation.

Authors:  Kunihiko Okano; Kenji Yamada; Katsuro Takahashi; Hiroshi Enomoto; Makoto Osaki; Hiroyuki Shindo
Journal:  Int Orthop       Date:  2009-05-16       Impact factor: 3.075

6.  Femoral head deformity after open reduction by Ludloff's medial approach.

Authors:  Kunihiko Okano; Hiroshi Enomoto; Makoto Osaki; Katsuro Takahashi; Hiroyuki Shindo
Journal:  Clin Orthop Relat Res       Date:  2008-06-27       Impact factor: 4.176

7.  Ligamentum teres maintenance and transfer as a stabilizer in open reduction for pediatric hip dislocation: surgical technique and early clinical results.

Authors:  Dennis R Wenger; Scott J Mubarak; Patrick C Henderson; Firoz Miyanji
Journal:  J Child Orthop       Date:  2008-04-29       Impact factor: 1.548

8.  Comparison of Open Reduction Alone and Open Reduction Plus Pemberton Osteotomy Techniques in the Treatment of Developmental Hip Dysplasia at Walking Age.

Authors:  Sinan Yilar; Serdar Toy; Mehmet Kose; Kutsi Tuncer; Naci Ezirmik; Ali Aydın; Kamber Kasali
Journal:  Eurasian J Med       Date:  2019-10

9.  A Comparative Study of Clinical and Radiological Outcomes of Open Reduction Using the Anterior and Medial Approaches for the Management of Developmental Dysplasia of the Hip.

Authors:  Omer Naci Ergin; Mehmet Demirel; Emre Meric; Volkan Sensoy; Fuat Bilgili
Journal:  Indian J Orthop       Date:  2020-06-20       Impact factor: 1.251

10.  The incidence of avascular necrosis following a cohort of treated developmental dysplasia of the hip in a single tertiary centre.

Authors:  Rahim Nawaz Hussain; Darius Rad; William John Watkins; Clare Carpenter
Journal:  J Child Orthop       Date:  2021-06-01       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.